ArticleBlood2022

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.

Marie Passet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.